4//SEC Filing
DelAversano Robert J 4
Accession 0001140361-25-014264
CIK 0001444192other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 8:58 PM ET
Size
18.9 KB
Accession
0001140361-25-014264
Insider Transaction Report
Form 4
DelAversano Robert J
Principal Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-14+20,130→ 20,130 totalExercise: $2.08Exp: 2035-04-14→ Common Stock (20,130 underlying)
Footnotes (1)
- [F1]This option vests quarterly in substantially equal installments over a 3-year period, subject to the Reporting Person's continuous service as of each vesting date.
Documents
Issuer
Grace Therapeutics, Inc.
CIK 0001444192
Entity typeother
Related Parties
1- filerCIK 0001728262
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 8:58 PM ET
- Size
- 18.9 KB